A low microRNA-630 expression confers resistance to tyrosine kinase inhibitors in EGFR-mutated lung adenocarcinomas via miR-630/YAP1/ERK feedback loop

Documenti analoghi

• Targeting the miR-630/YAP1/ERK feedback loop in epidermal growth factor receptor-mutated lung adenocarcinomas
  di: Zhang, Jinglin, et al.
  Pubblicazione: (2018)
• Dioscin overcome TKI resistance in EGFR-mutated lung adenocarcinoma cells via down-regulation of tyrosine phosphatase SHP2 expression
  di: Wang, Yao-Chen, et al.
  Pubblicazione: (2018)
• PD-L1 confers resistance to EGFR mutation-independent tyrosine kinase inhibitors in non-small cell lung cancer via upregulation of YAP1 expression
  di: Tung, Jai-Nien, et al.
  Pubblicazione: (2017)
• Expression of miR-630 associated with tyrosine kinase inhibitor therapeutic response in lung adenocarcinoma cases
  di: Das, Srijit
  Pubblicazione: (2019)
• The HIF-1α/PKM2 Feedback Loop in Relation to EGFR Mutational Status in Lung Adenocarcinoma
  di: Yuan Wang, et al.
  Pubblicazione: (2024-01-01)